We are live on
!
Find out more
DexCom
DXCM
DXCM
278 hedge funds and large institutions have $6.68B invested in DexCom in 2016 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 110 increasing their positions, 88 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
58% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 31
25% more capital invested
Capital invested by funds: $5.34B → $6.68B (+$1.34B)
25% more repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 88
6% more funds holding
Funds holding: 263 → 278 (+15)
8% less call options, than puts
Call options by funds: $42.8M | Put options by funds: $46.7M
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
278
Holders Change
+15
Holders Change %
+5.7%
% of All Funds
7.42%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.16%
New
49
Increased
110
Reduced
88
Closed
31
Calls
$42.8M
Puts
$46.7M
Net Calls
-$3.83M
Net Calls Change
-$9.01M
Top Buyers
Top Sellers
| 1 |
HM
HealthCor Management
New York
|
-$93.9M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$58.2M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$33M |
| 4 |
Goldman Sachs
New York
|
-$32.7M |
| 5 |
Renaissance Technologies
New York
|
-$32.4M |
